2222 State Street — Nashville, Tennessee

2222 State Street is a clinical research site located in Nashville, Tennessee, United States 37203.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

2222 State Street has participated in 1 clinical trials.

Therapeutic areas: Heartburn.

Sponsors: Novartis.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for 2222 State Street?

2222 State Street has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has 2222 State Street conducted?

2222 State Street has 1 clinical trials on record. Their work covers Heartburn.

Is 2222 State Street accredited by Crixeo Health?

2222 State Street has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about 2222 State Street?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.